Litigation Details for Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc. (S.D. Fla. 2014)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc. (S.D. Fla. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-08-15 |
Court | District Court, S.D. Florida | Date Terminated | 2014-10-30 |
Cause | Assigned To | Robin Lee Rosenberg | |
Jury Demand | Referred To | Dave Lee Brannon | |
Patents | 6,004,973; 6,239,124; 6,455,518 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc.
Details for Novartis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical, Inc. (S.D. Fla. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-08-15 | 1 | Complaint | United States Letters Patent No. 6,004,973 (“the ‘973 patent”). 'l`he ‘973 patent was duly and legally… United States Letters Patent No.5,665,772 (“the ‘772 patent”). The ‘772 patent was duly and legally issued…United States Letters Patent No. 6,239,124 (“the ‘ 124 patent”). The ‘ 124 patent was duly and legally …United States Letters Patent No. 6,455,518 (“the ‘5 1 8 patent”). The ‘518 patent was duly and legally …772, ‘973, ‘124, and ‘518 patents was an act of infringement of those patents. Case 9:14-cv-81067- | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |